Catalyst Wire Dossier Catalyst Wire Dossier

EGRIFTA WR

TESAMORELIN · Theratechnologies Inc.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for EGRIFTA WR, covering 2010-11-10 to 2025-03-25. Get the full timeline:

Most recent: FDA Approved: EGRIFTA WR — Supplemental Application (Theratechnologies Inc.)

See pricing